Leslie Monica, Silva Paulo, Paloyelis Yannis, Blevins James, Treasure Janet
Institute of Psychiatry, Psychology and Neuroscience (IoPPN), King's College London (KCL), London, United Kingdom.
VA Puget Sound Health Care System, Office of Research and Development Medical Research Service, Department of Veterans Affairs Medical Center, Seattle, WA, 98108, USA.
J Neuroendocrinol. 2018 Feb 26. doi: 10.1111/jne.12584.
Oxytocin's anorexigenic effects have been widely documented and accepted; however, no paper has yet used the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines to compile previous findings in a single systematic review and quantitative meta-analysis. The current paper aimed to identify published and unpublished studies examining the effects of oxytocin on energy intake in animals and humans, and the factors that moderate this effect.
Web of Science, Pub Med, and Ovid were searched for published and unpublished studies reporting the effects of oxytocin on energy intake in wild-type animals and in humans, when administered in the absence of other active drugs or surgery.
2049 articles were identified through the original systematic literature search, from which 54 articles were identified as relevant for inclusion in this review. An additional 3 relevant articles were identified in a later update of the literature search. Overall, a single-dose of oxytocin was found to reduce feeding in animals. Despite several individual studies which found that this effect persists to the end of the third week of chronic administration in rodent models, overall, this anorexigenic effect did not hold in the meta-analyses testing the effects of chronic administration. There was no overall effect of oxytocin on energy intake in humans, although a trend was identified for oxytocin to reduce consumption of solid foods.
Oxytocin reduces energy intake when administered as a single dose. Oxytocin can inhibit feeding over two- to three-week periods in rodent models. These effects typically do not persist beyond the third week of treatment. The anorexigenic effect of oxytocin is moderated by pregnant status, dose, method of administration, and diet composition. This article is protected by copyright. All rights reserved.
催产素的食欲抑制作用已得到广泛记载和认可;然而,尚无论文按照系统评价与Meta分析的首选报告项目(PRISMA)指南,在单一的系统评价和定量Meta分析中汇总以往的研究结果。本文旨在识别已发表和未发表的研究,这些研究探讨了催产素对动物和人类能量摄入的影响,以及调节这种作用的因素。
检索Web of Science、PubMed和Ovid,查找已发表和未发表的研究,这些研究报告了在无其他活性药物或手术的情况下,催产素对野生型动物和人类能量摄入的影响。
通过最初的系统文献检索,共识别出2049篇文章,其中54篇文章被确定与本综述相关。在随后的文献检索更新中,又识别出3篇相关文章。总体而言,发现单剂量催产素可减少动物的进食量。尽管有几项个体研究发现,在啮齿动物模型中,这种作用在慢性给药的第三周结束时仍然存在,但总体而言,在测试慢性给药效果的Meta分析中,这种食欲抑制作用并不成立。催产素对人类能量摄入没有总体影响,尽管发现有催产素减少固体食物摄入量的趋势。
单剂量使用催产素可减少能量摄入。在啮齿动物模型中,催产素可在两到三周的时间内抑制进食。这些作用通常在治疗第三周后不再持续。催产素的食欲抑制作用受妊娠状态、剂量、给药方法和饮食组成的调节。本文受版权保护。保留所有权利。